FREDERIC LOMBARD

About FREDERIC LOMBARD

Frédéric Lombard is Senior Vice President and Chief Financial Officer at Innate Pharma, a publicly listed biopharmaceutical company focused on immuno-oncology. He joined the company in April 2021, bringing more than 20 years of financial experience in the pharmaceutical industry. His career has been shaped by finance leadership, international team development, and the management of large-scale transformation initiatives in multicultural environments. At Innate Pharma, he plays a key role in financial planning, investor-facing communication, and supporting the company’s strategy as it advances its drug-candidate portfolio. Before joining Innate Pharma, Mr. Lombard held senior finance roles at Ipsen, AstraZeneca, and Novartis, giving him broad exposure to the financial and operational demands of major global pharmaceutical groups. His background has equipped him with expertise in corporate finance, management control, financial governance, and project execution. Innate Pharma notes that he has consistently focused on building international finance teams and positioning the finance function as a collaborative business partner rather than a purely reporting-oriented department. Earlier in his career, he worked in the information technology sector, where he became familiar with information systems standards in fast-changing environments. He holds a degree in Economics and Finance from Lyon 2 University and an MBA from emlyon business school. Overall, his profile combines financial discipline, international leadership, and transformation expertise, making him a significant executive figure within a listed biotech company.